Table 2 Univariate and multivariable level analysis of factors associated with COVID-19 mortality among PLWH

Age categories

  < 40

1

 40–49

1.96 (0.94–4.07)

2.24 (0.76–6.64)

  ≥ 50

2.88 (1.46–5.67)

2.32 (0.67–8.14)

Sex: Female

1.62 (1.04–2.52)

2.00 (0.85–4.67)

Smoker

2.86 (1.75–4.69)

4.17 (1.50–11.61)

Hypertension

1.32 (0.85–2.05)

0.93 (0.40–2.19)

Diabetes Mellitus

1.29 (0.82–2.04)

1.04 (0.51–2.16)

Chronic Kidney Disease

1.46 (0.73–2.93)

TB

1.35 (0.76–2.38)

Viral Load: Detectable

1.18 (0.65–2.16)

Congestive Heart Failure

1.87 (0.77–4.52)

Acute kidney injury

2.11 (1.36–3.30)

0.71 (0.33–1.57)

ARDS

1.17 (0.43–3.15)

Shock

1.22 (0.37–4.03)

Cough

0.88 (0.54–1.45)

Fever

0.87 (0.55–1.39)

Sore Throat

0.59 (0.23–1.50)

Myalgia

0.868 (0.50–1.52)

ARV therapy

1.04 (0.46–2.36)

*CD4: 200–499

1

 < 200

1.58 (0.94–2.65)

1.27 (0.62–2.61)

 ≥ 500

0.55 (0.22–1.38)

0.35 (0.09–1.29)

pa02

1.012 (0.96–1.07)

HGT

0.999 (0.973–1.03)

CRP

1.003 (1.001–1.005)

1.002 (1.002–1.01)

Creatinine

1.001 (1.001–1.002)

1.00 (0.99–1.00)

WCC

1.05 (1.01–1.08)

Neutrophils

1.024 (1.01–1.03)

1.03 (1.02–1.06)

HbA1c

1.01 (1.007–1.01)

1.01 (1.001–1.02)

Platelets

0.999 (0.997–1.00)

Lymphocytes

0.882 (0.58–1.34)